ArticleScientific reports2026
The impact of different exercise modes on prostate cancer: a Bayesian network meta-analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer (PCa) is one of the most prevalent malignancies in men. Although standard treatments, including surgery, androgen deprivation therapy (ADT), and radiotherapy, enhance survival, they frequently induce adverse effects such as muscle wasting, increased body fat mass, fatigue, and diminished quality of life. Exercise has emerged as a promising non-pharmacological intervention; however, the comparative efficacy of various exercise modalities remains inconclusive. A systematic review and Bayesian network meta-analysis were conducted to assess the effects of diverse exercise interventions on physical and quality-of-life outcomes in men with PCa. A comprehensive search of PubMed, Web of Science, the Cochrane Library, and Embase was conducted from inception through September 2025. Fifty-four randomized controlled trials (RCTs) involving 3,522 participants were included in the analysis. Primary outcomes included muscle strength, body fat mass, fatigue (FACIT-F), aerobic capacity (6-min walk test, 6WMT), and cancer-specific quality of life scores (EORTC QLQ-C30). Exercise interventions significantly improved muscle strength, body composition, fatigue, aerobic capacity, and quality of life compared to usual care. Resistance training (RT) may be the most beneficial intervention for enhancing muscle strength and aerobic capacity, aerobic training (AT) for reducing body fat, combined aerobic–resistance training (AT_RT) for alleviating fatigue, and high-intensity interval training (HIIT) for improving quality of life. All exercise modalities demonstrated good safety and feasibility, with no major adverse events reported. Exercise represents a safe and effective adjunctive therapy for prostate cancer rehabilitation. Incorporating individualized exercise prescriptions—specifically RT, AT, AT_RT, and HIIT—into clinical practice can optimize physical outcomes, mitigate treatment-related side effects, and enhance the quality of life among prostate cancer survivors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.